World Trade Center Health Program Publishes Notice of Proposed Rulemaking

World Trade Center Health Program Publishes Notice of Proposed Rulemaking

The WTC Health Program is considering adding uterine cancer to the WTC-Related Conditions list.

A new condition could be added to the World Trade Center (WTC) Related Conditions, a program that allows specific people affected by 9/11 to receive no-cost treatment.

According to a press release, the WTC Health Program published a notice of proposed rulemaking last week. The program, administered by NIOSH, is considering adding uterine cancer to the World Trade Center-Related Conditions list. Currently, uterine cancer is the only type of cancer not under the list.

Under the program, people who are diagnosed with conditions under the list and were directly affected by the 9/11 attacks can qualify to receive treatment at no cost.

“We know that WTC Health Program members continue to face health challenges that stem from their exposures on or in the months after 9/11,” said John Howard, M.D., administrator of the WTC Health Program and director of the National Institute for Occupational Safety and Health in the press release. “The proposed rule published today in the Federal Register is the next step toward ensuring women who are enrolled in the WTC Health Program have access to the cancer care and treatment they need if their uterine cancer is related to their 9/11 exposures.”

The proposed rule is open to comment from the public until June 24, 2022. Comments can be submitted online, CDC-2022-0052, or by writing the NIOSH Docket Office.

About the Author

Alex Saurman is a former Content Editor for Occupational Health & Safety,who has since joined OH&S’s client services team. She continues to work closely with OH&S’s editorial team and contributes to the magazine.

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" 3

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. 3

  • EMSL Analytical, Inc. - Air Sampling Supplies & Testing Labs

    EMSL Analytical, Inc. operates laboratories throughout the United States and Canada. EMSL is a nationally recognized and locally focused provider specializing in fast laboratory results for Asbestos, Mold, Silica, Lead & Metals, Bacteria, Legionella, USP , Combustion By-Products, VOC’s, Radon, PCB’s, Formaldehyde, METH/Fentanyl, Identification of Dust & Unknowns. Sampling Pumps, Cassettes, Media & Supplies available. Reach us at 1-800.220.3675 3

Featured